Narayana Hrudayalaya announced that Health City Cayman Islands (HCCI), a wholly owned overseas subsidiary of the Company has infused an amount of USD 1.5 Million in Cayman Integrated Healthcare (CIHL), a wholly-owned overseas subsidiary of HCCI and a step-down subsidiary of the Company by way of subscription to its equity shares equivalent to USD 1.5 Million, i.e., 150,000 ordinary shares in the capital of the Company, each as fully paid, with the value of each ordinary shares being set at US$ 10.00, which is comprised US$0.01 of par value and US$ 9.99 of share premium. The above-mentioned shares have been allotted by CIHL to HCCI on 06 December 2024 (Friday). With this investment, the total investment of HCCI in CIHL stands at USD 5,550,000.Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya declined 12.34% to Rs 198.63 crore in the quarter ended September 2024 as against Rs 226.58 crore during the previous quarter ended September 2023. Sales rose 7.26% to Rs 1400.01 crore in the quarter ended September 2024 as against Rs 1305.25 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1400.011305.25 7 OPM %22.0323.61 - PBDT296.90303.66 -2 PBT231.77248.39 -7 NP198.63226.58 -12 Powered by Capital Market - Live

Narayana Hrudayalaya will hold a meeting of the Board of Directors of the Company on 31 October 2024.Powered by Capital Market - Live

Aegis Logistics Ltd, Prism Johnson Ltd, BLS International Services Ltd and Ajanta Pharma Ltd are among the other losers in the BSE's 'A' group today, 13 September 2024.Narayana Hrudayalaya Ltd lost 4.39% to Rs 1310 at 14:45 IST.The stock was the biggest loser in the BSE's 'A' group.On the BSE, 21074 shares were traded on the counter so far as against the average daily volumes of 26482 shares in the past one month.Aegis Logistics Ltd crashed 4.34% to Rs 801. The stock was the second biggest loser in 'A' group.On the BSE, 17945 shares were traded on the counter so far as against the average daily volumes of 33779 shares in the past one month.Prism Johnson Ltd tumbled 3.92% to Rs 211. The stock was the third biggest loser in 'A' group.On the BSE, 1.17 lakh shares were traded on the counter so far as against the average daily volumes of 2.95 lakh shares in the past one month.BLS International Services Ltd pared 3.91% to Rs 439.5. The stock was the fourth biggest loser in 'A' group.On the BSE, 4.91 lakh shares were traded on the counter so far as against the average daily volumes of 2.87 lakh shares in the past one month.Ajanta Pharma Ltd dropped 3.38% to Rs 3275. The stock was the fifth biggest loser in 'A' group.On the BSE, 8054 shares were traded on the counter so far as against the average daily volumes of 9591 shares in the past one month.Powered by Capital Market - Live

India revenue stood at Rs 1,085.5 crore (up 9.7% YoY) and Cayman revenue (includes HCCI and EICL entities) was Rs 267.4 crore (up 4.8% YoY). Consolidated EBITDA grew by 14.6% to Rs 327.4 crore in June 2024 quarter from Rs 285.8 crore in Q1 FY24. EBITDA margin improved to 24.4% in Q1 FY25 as against 23.% in Q1 FY24. As on 30 June 2024, the total borrowings less cash & bank balance and current investments was Rs 154.9 crore, representing a net debt to equity ratio of 0.03 (out of which, debt worth $75 million is foreign currency denominated). Dr. Emmanuel Rupert, managing director and group CEO, Narayana Hrudayalaya, commented: ''The first quarter of the new fiscal year has started with a robust performance. We are pleased to report the highest-ever revenue on a quarterly basis with profitability sustained at high levels, which is on account of improvement in realizations and increased patient footfalls. The performance improvement is supported by strong growth in business across our flagship units, other hospitals, and steady improvements in the performance of our newer hospitals. HCCI continues to deliver strong performance on both revenue and profitability for the current quarter. NHIC has delivered another strong quarter of increased patient transactions. We are confident of delivering on our expectations for the new fiscal year.' Narayana Hrudayalaya is one of the leading healthcare service providers in India, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The company has a network of 18 hospitals and 3 heart centers across India along with overseas presence at Cayman Islands, with over 5,790 operational beds and a capacity of over 6,250 beds. The scrip declined 1.84% to end at Rs 1,230.15 on Friday, 2 August 2024. Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya rose 9.46% to Rs 86.41 crore in the quarter ended June 2024 as against Rs 78.94 crore during the previous quarter ended June 2023. Sales rose 9.41% to Rs 871.76 crore in the quarter ended June 2024 as against Rs 796.80 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales871.76796.80 9 OPM %17.9617.28 - PBDT149.84133.74 12 PBT110.4996.00 15 NP86.4178.94 9 Powered by Capital Market - Live

Net profit of Narayana Hrudayalaya rose 9.48% to Rs 201.38 crore in the quarter ended June 2024 as against Rs 183.95 crore during the previous quarter ended June 2023. Sales rose 8.72% to Rs 1340.95 crore in the quarter ended June 2024 as against Rs 1233.43 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales1340.951233.43 9 OPM %22.6621.95 - PBDT293.34264.82 11 PBT231.69205.94 13 NP201.38183.95 9 Powered by Capital Market - Live